BridgeMD
New treatment option for Cardiogenic Shock
Official title Physiology of Unloading VA ECMO Trial
ClinicalTrials.gov ID: NCT06336655
What this study is testing
- What it's testing
- The goal of this clinical trial is to compare the use of veno-arterial extracorporeal membrane oxygenation (VA ECMO) with and without left ventricular (LV) unloading in patients being treated for cardiogenic shock (CS). The main aims of the study are: 1.
- Phase 2: a mid-size study of how well it works
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult patients (age 18 years or older)
- Diagnosis of acute cardiogenic shock (CS)
- Patients failing medical therapy, defined as 1 or more of the following:
- Society for Coronary Angiography and Interventions (SCAI) Stage C or greater
- 2 or more inotropic medications and not improving
You likely can't join if
- Metastatic or stage 4 cancer
- Atrial septostomy
- Planned LV unloading on ECMO
- Anticipated death \<72 hours
- Existing durable left ventricular assist device (dLVAD)
- Unwillingness to randomize
See the full eligibility criteria
- Adult patients (age 18 years or older)
- Diagnosis of acute cardiogenic shock (CS)
- Patients failing medical therapy, defined as 1 or more of the following:
- Society for Coronary Angiography and Interventions (SCAI) Stage C or greater
- 2 or more inotropic medications and not improving
- IABP in place and clinically worsening
- Placed on VA ECMO for CS
- In the opinion of the attending physician, patient has worsening CS and could require VA ECMO support in the near-term
- Metastatic or stage 4 cancer
- Atrial septostomy
- Planned LV unloading on ECMO
- Anticipated death \<72 hours
- Existing durable left ventricular assist device (dLVAD)
- Unwillingness to randomize
- Patients who are pregnant
The study team makes the final eligibility decision.
Where it's taking place
- Salt Lake City, Utah, United States
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Salt Lake City, Utah, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.